Posters

The STARflo glaucoma implant: results and experiences after follow-up of 24 months in St. Johannes-Hospital in Dortmund

Poster Details

First Author: S.Fili GERMANY

Co Author(s): I. Vastardis   P. Woelfelschneider   M. Kohlhaas              

Abstract Details

Purpose:

To investigate the safety and effectiveness of the Starflo implant. The results of 2 years follow-up are presented in patients with open-angle glaucoma, PEX-Gaucom and congenital glaucoma.

Setting:

Clinic of Ophthalmology, St.-Johannes-Hospital in Dortmund, Germany

Methods:

A prospective study with a total of over 33 patients, in which the suprachoroidal implantation of the StarfloTM was indicated for long-term intraocular pressure reduction is still in process and evaluation.

Results:

No intraoperative complications have been reported after the implantation of Starflo. Postoperative complications include hyphema and fibrin formation in the anterior chamber, which were completely resorbed after the first postoperative month. A postoperative bulbar hypertension was the most common complication after the first 3 months. The reduction of IOP was satisfying after 6 months. The reduction of the local antiglaucoma drops was significant for a maximum of two substance 6 bis 24 months postoperatively.

Conclusions:

The Starflo implant appears to be a safe and effective alternative treatment method for patients with refractory open-angle glaucoma to conventional glaucoma surgery.

Financial Disclosure:

None